Phase I Clinical Trial of the Mammalian Target of Rapamycin Inhibitor Everolimus in Combination With Oral Topotecan for Recurrent and Advanced Endometrial Cancer
Titel:
Phase I Clinical Trial of the Mammalian Target of Rapamycin Inhibitor Everolimus in Combination With Oral Topotecan for Recurrent and Advanced Endometrial Cancer
Auteur:
Acevedo-Gadea, Carlos Santin, Alessandro D. Higgins, Susan A. Urva, Shweta Ratner, Elena Silasi, Dan-Arin Azodi, Masoud Rutherford, Thomas Schwartz, Peter E. Abu-Khalaf, Maysa M.